Users Stopping Slimming Injections Gain Back Pounds Far More Rapidly Than Those on Conventional Diets

Fresh analysis reveals that patients who discontinue new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who end conventional lifestyle programs.

Findings released in a prominent health publication shows that while overweight individuals can lose a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing such treatments should be informed of the risk of quick rebound weight gain when the treatment ends," warns expert Dr. Susan Jebb.

That rate of regain suggests a reversion to original weight within about one and a half years.

Weighing Approaches

The research, which reviewed 37 of studies involving thousands of participants, compared the results of the injectable medications with other pills.

Scientists point out that people who lose weight through lifestyle changes alone generally see a slower creep back—perhaps 100 grams monthly—post-intervention.

Explaining the Quick Regain

Nutrition scientists propose the mode of action of the drugs accounts for the amplified rebound.

These medications imitate a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Sustained high doses of the hormone levels far above than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its effects," noted Dr. Adam Collins, a dietetics expert.

"Withdrawal of this medication leads to hunger is unsuppressed, making binge eating far more likely."

A Chronic Condition?

Health authorities advise the injections for individuals with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications.

A number of clinicians say that, due to the high risk of relapse, the therapy might need to be ongoing.

This opinion is reinforced by drug manufacturers, who note that the results "highlight the persistent nature of excess weight," comparing it to managing conditions like hypertension.

Patient Testimonies

Individuals who have come off the medication explain a intense resurgence of appetite.

"It felt as if something that goes on and you become ravenous," said one woman.

The struggle is worsened if users have not established permanent dietary or behavioural changes during treatment.

Widespread Use

Figures suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.

• Adoption is more common among females than men.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion obtain the medications through private healthcare rather than public health services.

Finally, clinicians caution that while these medications are powerful agents for weight loss, they are not a permanent cure and maintained weight loss hinges on ongoing lifestyle support.